Currently predicting for Thu, 4 Jun 2026

GNPX Prediction Chart

GNPX Predictions History

Latest community submissions for GNPX.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Feb 14, 2022 $2.21 -97.54% $2.20 V 99.55% 5
Feb 14, 2022 Bearish $2.20 V 1
JS JS Pro
Jan 15, 2021 $3.77 -97.49% $3.75 V 99.47% 4
Peter Peter @Peter.189008
Jan 15, 2021 Bearish $3.75 V 1
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Sep 21, 2020 $3.82 -97.35% $3.61 X 94.18% 0
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Jul 29, 2020 Bearish $3.47 V 1
JS JS Pro
Jul 29, 2020 $3.59 -97.41% $3.47 V 96.54% 1
iHustle84 iHustle84 Pro
Jul 29, 2020 $2.56 -98.16% $3.47 V 73.78% 1
JS JS Pro
Apr 27, 2020 $2.25 -97.63% $2.37 V 94.94% 0
Apr 27, 2020 Bearish $2.37 V 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GNPX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GENPREX INC.
Genprex
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas....
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE